Literature DB >> 4338589

3-Cyclic amine derivatives of rifamycin: strong inhibitors of the DNA polymerase activity of RNA tumor viruses.

M Green, J Bragdon, A Rankin.   

Abstract

Derivatives of rifamycin-SV with substituted cyclic-amine side chains in position 3 of the ansa ring are strong inhibitors of RNA-directed DNA and DNA-directed DNA polymerase activity of RNA tumor viruses of murine, feline, and avian origin. Among 37 3-amine derivatives of rifamycin-SV that were tested, 29 3-cyclic amine derivatives were good inhibitors of the viral polymerases. Especially active were 3-piperidyl derivatives of rifamycin-SV with cyclohexyl and cyclohexylalkyl substituents. Derivatives that were effective against the viral polymerase also blocked cell transformation by the murine sarcoma virus. A DNA-directed DNA polymerase preparation from human KB cells was less sensitive to inhibition by these derivatives than the virion polymerase.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4338589      PMCID: PMC426685          DOI: 10.1073/pnas.69.5.1294

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  7 in total

1.  Inhibitors of the RNA and DNA dependent polymerase activities of RNA tumour viruses.

Authors:  C Gurgo; R K Ray; L Thiry; M Green
Journal:  Nat New Biol       Date:  1971-01-27

2.  Formation of viral RNA-DNA hybrid molecules by the DNA polymerase of sarcoma-leukaemia viruses.

Authors:  M Rokutanda; H Rokutanda; M Green; K Fujinaga; R K Ray; C Gurgo
Journal:  Nature       Date:  1970-09-05       Impact factor: 49.962

Review 3.  Actions of the rifamycins.

Authors:  W Wehrli; M Staehelin
Journal:  Bacteriol Rev       Date:  1971-09

4.  Effect of rifampicin and two of its derivatives on cells infected with Moloney sarcoma virus.

Authors:  M Calvin; U R Joss; A J Hackett; R B Owens
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

5.  Mechanism of carcinogenesis by RNA tumor viruses. 3. Formation of RNA, DNA complex and duplex DNA molecules by the DNA polymerase (s) of avian myeloblastosis virus.

Authors:  K Fujinaga; J T Parsons; J W Beard; D Beard; M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

6.  Mechanism of carcinogenesis by RNA tumor viruses. I. An RNA-dependent DNA polymerase in murine sarcoma viruses.

Authors:  M Green; M Rokutanda; K Fujinaga; R K Ray; H Rokutanda; C Gurgo
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

7.  Murine sarcoma virus transformation of BALB-3T3 cells: lack of dependence on murine leukemia virus.

Authors:  S A Aaronson; J L Jainchill; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1970-08       Impact factor: 11.205

  7 in total
  8 in total

1.  Inhibition of three nucleotide polymerases by rifamycin derivatives.

Authors:  F M Thompson; A N Tischler; J Adams; M Calvin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

2.  Study of ansamycin inhibition of a ribonucleic acid-directed deoxyribonucleic acid polymerase by an immobilized template assay.

Authors:  B I Milavetz; J S Horoszewicz; K L Rinehart; W A Carter
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

3.  Differential susceptibility of spleen focus-forming virus and murine leukemia viruses to ansamycin antibiotics.

Authors:  J S Horoszewicz; S S Leong; W A Carter
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

4.  Inhibition of infectious Rous sarcoma virus production by rifamycin derivative.

Authors:  C Szabo; M J Bissell; M Calvin
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

5.  Preferential inhibition of the growth of virus-transformed cells in culture by rifazone-82, a new rifamycin derivative.

Authors:  M J Bissell; C Hatie; A N Tischler; M Calvin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

6.  The specificity of dimethylbenzylrifampicin as an inhibitor of viral induced transformation.

Authors:  H S Smith; A J Hackett
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

7.  DNA-polymerase inhibitors. Rifamycin derivatives.

Authors:  L Y Frolova; Y A Meldrays; L L Kochkina; S A Giller; A V Eremeyev; N A Grayevskaya; L L Kisselev
Journal:  Nucleic Acids Res       Date:  1977-03       Impact factor: 16.971

8.  Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.

Authors:  Xijing Qian; Bingan Wu; Hailin Tang; Zhenghan Luo; Zhenghao Xu; Songying Ouyang; Xiangliang Li; Jianfeng Xie; Zhigang Yi; Qibin Leng; Yan Liu; Zhongtian Qi; Ping Zhao
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.